Research Article
Sarcopenia Does Not Affect Survival or Outcomes in Soft-Tissue Sarcoma
Table 1
Demographic and clinical statistics.
| | | | Range |
| | Median age (years) | 59 | (42–70) | | Median height (meters) | 1.72 | (1.6–1.8) |
| | | | Percentage |
| | Gender | Male () | 50% | | Female () | 50% | | Body mass index (BMI) | BMI < 30 () | 63% | | BMI 30–35 () | 22% | | BMI 35–40 () | 9% | | BMI 40–45 () | 3% | | BMI > 45 () | 3% | | Surgery | Wide local excision () | 92% | | Amputation () | 8% | | Surgical margins | Negative () () | 88% | | Positive () () | 12% |
| | | | Range |
| | Median follow-up (years) | 4.1 | (1.7–5.6) | | Median tumor size (cm) | 9.0 | (5.0–15.0) | | Median time to death (months) | 69 | (40–89) |
| | | | Percentage |
| | Tumor depth (relative to investing fascia) | Superficial () | 20% | | Deep () | 80% | | Tumor grade | Low () | 18% | | Intermediate () | 11% | | High () | 71% | | Histologic sarcoma type | Fibrosarcoma () | 4% | | Leiomyosarcoma () | 12% | | Liposarcoma () | 22% | | Malignant peripheral nerve sheath tumor () | 2% | | Undifferentiated pleiomorphic sarcoma () | 42% | | Synovial sarcoma () | 5% | | Vascular sarcoma () | 4% | | Rhabdomyosarcoma () | 1% | | Others () | 9% | | AJCC stage at presentation | I () | 25% | | II () | 20% | | III () | 24% | | IV () | 31% | | Preoperative radiation | Yes () | 23% | | No () | 77% | | Postoperative radiation | Yes () | 61% | | No () | 39% | | Chemotherapy | Yes () | 21% | | No () | 79% | | Survival status at last follow-up | Alive () | 69% | | Died of disease () | 17% | | Died of other causes () | 7% | | Uncertain cause of death () | 4% |
|
|
